Literature DB >> 7816867

Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization.

F J Wan1, M A Geyer, N R Swerdlow.   

Abstract

The normal reduction in acoustic startle amplitude caused by a weak prepulse (prepulse inhibition; PPI) is deficient in schizophrenic patients and in rats after systemic or intraaccumbens treatment with the D2 dopamine agonist quinpirole. We examined the anatomical substrates of the PPI-disruptive effects of intraaccumbens quinpirole. PPI was significantly reduced in a dose-dependent manner by quinpirole infusion into the medial accumbens shell region, the lateral accumbens core region, and an intermediate central region. There was a weak tendency for this quinpirole effect to be more pronounced in core and central accumbens regions than in the medial and anteromedial accumbens. Using the retrograde tracer Nuclear yellow, shell and core regions were verified to receive different patterns of limbic cortical innervation. Although the accumbens appears to have a complex and functionally diversified intrinsic anatomy, the accumbens D2 modulation of sensorimotor gating appears to be distributed across several different accumbens subregions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816867     DOI: 10.1016/0091-3057(94)90470-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  15 in total

1.  Repeated quinpirole treatments produce neurochemical sensitization and associated behavioral changes in female hamsters.

Authors:  Julia A Chester; Amanda J Mullins; Chau H Nguyen; Val J Watts; Robert L Meisel
Journal:  Psychopharmacology (Berl)       Date:  2006-07-19       Impact factor: 4.530

2.  Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.

Authors:  Ying Qu; Neal R Swerdlow; Martin Weber; David Stouffer; Loren H Parsons
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

3.  Probing the molecular basis for an inherited sensitivity to the startle-gating disruptive effects of apomorphine in rats.

Authors:  Neal R Swerdlow; Michelle R Breier; Richard L Saint Marie
Journal:  Psychopharmacology (Berl)       Date:  2011-03-02       Impact factor: 4.530

4.  Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

Authors:  Karen M Alsene; Katie Fallace; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

5.  Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine.

Authors:  J F C Pedrazzi; A C Issy; F V Gomes; F S Guimarães; E A Del-Bel
Journal:  Psychopharmacology (Berl)       Date:  2015-05-06       Impact factor: 4.530

6.  Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

Review 7.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

8.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.

Authors:  Arnt F A Schellekens; K P Grootens; C Neef; Kris L L Movig; J K Buitelaar; B Ellenbroek; R J Verkes
Journal:  Psychopharmacology (Berl)       Date:  2009-10-16       Impact factor: 4.530

9.  Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2007-05-09       Impact factor: 3.590

10.  Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating.

Authors:  F J Wan; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.